Programmed self-assembly of peptide–major histocompatibility complex for antigen-specific immune modulation

Chih Ping Mao, Shiwen Peng, Andrew Yang, Liangmei He, Ya Chea Tsai, Chien-Fu Hung, Tzyy Choou Wu

Research output: Contribution to journalArticle

Abstract

A technology to prime desired populations of T cells in the body—particularly those that possess low avidity against target antigen—would pave the way for the design of new types of vaccination for intractable infectious diseases or cancer. Here, we report such a technology based on positive feedback-driven, programmed self-assembly of peptide–major histocompatibility complex (pMHC) directly on the membrane of cognate T cells. Our design capitalizes on the unique features of the protein annexin V (ANXA5), which—in a concerted and synergistic manner—couples the early onset of TCR signaling by cognate pMHC with a surge in pMHC–TCR affinity, with repeated pMHC encounters, and with widespread TCR cross-linking. In our system, ANXA5 is linked to pMHC and firmly engages the plasma membrane of cognate T cells upon (and only upon) the early onset of TCR signaling. ANXA5, in turn, exerts a mechanical force that stabilizes interactions at the TCR–pMHC interface and facilitates repeated, serial pMHC encounters. Furthermore, ANXA5 quickly arranges into uniform 2D matrices, thereby prompting TCR cross-linking. Fusion of ANXA5 to pMHC augments lymphocyte activation by several orders of magnitude (>1,000-fold), bypasses the need for costimulation, and breaks tolerance against a model self-antigen in vivo. Our study opens the door to the application of synthetic, feedback-driven self-assembly platforms in immune modulation.

Original languageEnglish (US)
Pages (from-to)E4032-E4040
JournalProceedings of the National Academy of Sciences of the United States of America
Volume115
Issue number17
DOIs
StatePublished - Apr 24 2018

Fingerprint

Histocompatibility Antigens
Major Histocompatibility Complex
T-Lymphocytes
Technology
Annexin A5
Autoantigens
Lymphocyte Activation
Communicable Diseases
Vaccination
Cell Membrane
Membranes
Population
Neoplasms
Proteins

Keywords

  • T cell signaling | immune modulation | antigen-specific lymphocyte | annexin V | protein self-assembly

ASJC Scopus subject areas

  • General

Cite this

Programmed self-assembly of peptide–major histocompatibility complex for antigen-specific immune modulation. / Mao, Chih Ping; Peng, Shiwen; Yang, Andrew; He, Liangmei; Tsai, Ya Chea; Hung, Chien-Fu; Wu, Tzyy Choou.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 115, No. 17, 24.04.2018, p. E4032-E4040.

Research output: Contribution to journalArticle

@article{7e1ab26f14194c87903341604c16beac,
title = "Programmed self-assembly of peptide–major histocompatibility complex for antigen-specific immune modulation",
abstract = "A technology to prime desired populations of T cells in the body—particularly those that possess low avidity against target antigen—would pave the way for the design of new types of vaccination for intractable infectious diseases or cancer. Here, we report such a technology based on positive feedback-driven, programmed self-assembly of peptide–major histocompatibility complex (pMHC) directly on the membrane of cognate T cells. Our design capitalizes on the unique features of the protein annexin V (ANXA5), which—in a concerted and synergistic manner—couples the early onset of TCR signaling by cognate pMHC with a surge in pMHC–TCR affinity, with repeated pMHC encounters, and with widespread TCR cross-linking. In our system, ANXA5 is linked to pMHC and firmly engages the plasma membrane of cognate T cells upon (and only upon) the early onset of TCR signaling. ANXA5, in turn, exerts a mechanical force that stabilizes interactions at the TCR–pMHC interface and facilitates repeated, serial pMHC encounters. Furthermore, ANXA5 quickly arranges into uniform 2D matrices, thereby prompting TCR cross-linking. Fusion of ANXA5 to pMHC augments lymphocyte activation by several orders of magnitude (>1,000-fold), bypasses the need for costimulation, and breaks tolerance against a model self-antigen in vivo. Our study opens the door to the application of synthetic, feedback-driven self-assembly platforms in immune modulation.",
keywords = "T cell signaling | immune modulation | antigen-specific lymphocyte | annexin V | protein self-assembly",
author = "Mao, {Chih Ping} and Shiwen Peng and Andrew Yang and Liangmei He and Tsai, {Ya Chea} and Chien-Fu Hung and Wu, {Tzyy Choou}",
year = "2018",
month = "4",
day = "24",
doi = "10.1073/pnas.1718434115",
language = "English (US)",
volume = "115",
pages = "E4032--E4040",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "17",

}

TY - JOUR

T1 - Programmed self-assembly of peptide–major histocompatibility complex for antigen-specific immune modulation

AU - Mao, Chih Ping

AU - Peng, Shiwen

AU - Yang, Andrew

AU - He, Liangmei

AU - Tsai, Ya Chea

AU - Hung, Chien-Fu

AU - Wu, Tzyy Choou

PY - 2018/4/24

Y1 - 2018/4/24

N2 - A technology to prime desired populations of T cells in the body—particularly those that possess low avidity against target antigen—would pave the way for the design of new types of vaccination for intractable infectious diseases or cancer. Here, we report such a technology based on positive feedback-driven, programmed self-assembly of peptide–major histocompatibility complex (pMHC) directly on the membrane of cognate T cells. Our design capitalizes on the unique features of the protein annexin V (ANXA5), which—in a concerted and synergistic manner—couples the early onset of TCR signaling by cognate pMHC with a surge in pMHC–TCR affinity, with repeated pMHC encounters, and with widespread TCR cross-linking. In our system, ANXA5 is linked to pMHC and firmly engages the plasma membrane of cognate T cells upon (and only upon) the early onset of TCR signaling. ANXA5, in turn, exerts a mechanical force that stabilizes interactions at the TCR–pMHC interface and facilitates repeated, serial pMHC encounters. Furthermore, ANXA5 quickly arranges into uniform 2D matrices, thereby prompting TCR cross-linking. Fusion of ANXA5 to pMHC augments lymphocyte activation by several orders of magnitude (>1,000-fold), bypasses the need for costimulation, and breaks tolerance against a model self-antigen in vivo. Our study opens the door to the application of synthetic, feedback-driven self-assembly platforms in immune modulation.

AB - A technology to prime desired populations of T cells in the body—particularly those that possess low avidity against target antigen—would pave the way for the design of new types of vaccination for intractable infectious diseases or cancer. Here, we report such a technology based on positive feedback-driven, programmed self-assembly of peptide–major histocompatibility complex (pMHC) directly on the membrane of cognate T cells. Our design capitalizes on the unique features of the protein annexin V (ANXA5), which—in a concerted and synergistic manner—couples the early onset of TCR signaling by cognate pMHC with a surge in pMHC–TCR affinity, with repeated pMHC encounters, and with widespread TCR cross-linking. In our system, ANXA5 is linked to pMHC and firmly engages the plasma membrane of cognate T cells upon (and only upon) the early onset of TCR signaling. ANXA5, in turn, exerts a mechanical force that stabilizes interactions at the TCR–pMHC interface and facilitates repeated, serial pMHC encounters. Furthermore, ANXA5 quickly arranges into uniform 2D matrices, thereby prompting TCR cross-linking. Fusion of ANXA5 to pMHC augments lymphocyte activation by several orders of magnitude (>1,000-fold), bypasses the need for costimulation, and breaks tolerance against a model self-antigen in vivo. Our study opens the door to the application of synthetic, feedback-driven self-assembly platforms in immune modulation.

KW - T cell signaling | immune modulation | antigen-specific lymphocyte | annexin V | protein self-assembly

UR - http://www.scopus.com/inward/record.url?scp=85045896361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045896361&partnerID=8YFLogxK

U2 - 10.1073/pnas.1718434115

DO - 10.1073/pnas.1718434115

M3 - Article

C2 - 29632186

AN - SCOPUS:85045896361

VL - 115

SP - E4032-E4040

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 17

ER -